{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=beta+blockers&page=3", "query": { "intervention": "beta blockers", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 216, "total_pages": 22, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=beta+blockers&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=beta+blockers&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T11:13:39.174Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00507663", "title": "Elder Surgery - Functional Recovery Following Beta Blockade", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Post Operative Cognitive Dysfunction" ], "interventions": [ { "name": "Atenolol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 359, "start_date": "2002-09", "completion_date": "2007-11", "has_results": false, "last_update_posted_date": "2016-03-16", "last_synced_at": "2026-10-25T11:13:39.174Z", "location_count": 3, "location_summary": "Rochester, Minnesota • New York, New York", "locations": [ { "city": "Rochester", "state": "Minnesota" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00507663" }, { "nct_id": "NCT01970501", "title": "Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Current or Recent History of Atrial Fibrillation" ], "interventions": [ { "name": "bucindolol hydrochloride", "type": "DRUG" }, { "name": "metoprolol succinate", "type": "DRUG" }, { "name": "Placebo oral capsule", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "ARCA Biopharma, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 267, "start_date": "2014-04", "completion_date": "2017-12-28", "has_results": true, "last_update_posted_date": "2022-09-26", "last_synced_at": "2026-10-25T11:13:39.174Z", "location_count": 48, "location_summary": "Anchorage, Alaska • Phoenix, Arizona • East Palo Alto, California + 43 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "East Palo Alto", "state": "California" }, { "city": "Loma Linda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01970501" }, { "nct_id": "NCT05968690", "title": "Naltrexone and Propranolol Combined With Immunotherapy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Melanoma" ], "interventions": [ { "name": "Propranolol", "type": "DRUG" }, { "name": "Naltrexone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sarah Weiss", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2023-09-11", "completion_date": "2027-09-30", "has_results": false, "last_update_posted_date": "2025-09-18", "last_synced_at": "2026-10-25T11:13:39.174Z", "location_count": 1, "location_summary": "New Brunswick, New Jersey", "locations": [ { "city": "New Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05968690" }, { "nct_id": "NCT02053246", "title": "Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart Failure", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Hypertension", "Diastolic Heart Failure", "Heart Failure With Preserved Ejection Fraction" ], "interventions": [ { "name": "Nebivolol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2014-01", "completion_date": "2021-03", "has_results": true, "last_update_posted_date": "2022-02-10", "last_synced_at": "2026-10-25T11:13:39.174Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02053246" }, { "nct_id": "NCT01094574", "title": "Evaluation of Propranolol's Effect on Pain and Inflammation.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain Measurement" ], "interventions": [ { "name": "Alfentanil", "type": "DRUG" }, { "name": "Propranolol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Martin Angst", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 10, "start_date": "2010-01", "completion_date": "2010-08", "has_results": true, "last_update_posted_date": "2017-02-24", "last_synced_at": "2026-10-25T11:13:39.174Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01094574" }, { "nct_id": "NCT07252310", "title": "Pilot Study of StudyU for N-of-1 Trials in HFrEF Patients (N-of-1 App)", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "HFrEF - Heart Failure With Reduced Ejection Fraction", "Heart Failure", "Heart Failure, Systolic", "Heart Diseases" ], "interventions": [ { "name": "beta blockers", "type": "DRUG" }, { "name": "StudyU Application", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 5, "start_date": "2026-02-10", "completion_date": "2027-08", "has_results": false, "last_update_posted_date": "2026-02-19", "last_synced_at": "2026-10-25T11:13:39.174Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07252310" }, { "nct_id": "NCT00753168", "title": "Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Glaucoma, Open-Angle", "Ocular Hypertension" ], "interventions": [ { "name": "OT-730 ophthalmic solution", "type": "DRUG" }, { "name": "timolol maleate ophthalmic solution", "type": "DRUG" }, { "name": "OT-730 placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Othera Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 48, "start_date": "2008-09", "completion_date": "2008-12", "has_results": false, "last_update_posted_date": "2009-01-07", "last_synced_at": "2026-10-25T11:13:39.174Z", "location_count": 5, "location_summary": "Artesia, California • Roswell, Georgia • Charlotte, North Carolina + 2 more", "locations": [ { "city": "Artesia", "state": "California" }, { "city": "Roswell", "state": "Georgia" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "High Point", "state": "North Carolina" }, { "city": "Mt. Pleasant", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00753168" }, { "nct_id": "NCT00430612", "title": "The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Myocardial Infarction" ], "interventions": [], "intervention_types": [], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 7057, "start_date": "2009-05", "completion_date": "2015-10", "has_results": false, "last_update_posted_date": "2023-04-24", "last_synced_at": "2026-10-25T11:13:39.174Z", "location_count": 22, "location_summary": "Little Rock, Arkansas • Long Beach, California • Los Angeles, California + 19 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Bridgeport", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00430612" }, { "nct_id": "NCT06069102", "title": "Optimal Blood Pressure Treatment Thresholds Postpartum", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertensive Disorder of Pregnancy", "Pre-Eclampsia", "Hypertension", "Eclampsia", "Gestational Hypertension", "Cardiovascular Diseases", "Toxemia", "Pregnancy Complications", "Vascular Diseases", "Hypertension, Pregnancy Induced", "Hypertension;Pre-Eclamptic" ], "interventions": [ { "name": "Usual care", "type": "DRUG" }, { "name": "Tight blood pressure control", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alisse Hauspurg", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "FEMALE", "summary": "18 Years to 55 Years · Female only" }, "enrollment_count": 61, "start_date": "2023-11-15", "completion_date": "2025-12-01", "has_results": true, "last_update_posted_date": "2026-06-02", "last_synced_at": "2026-10-25T11:13:39.174Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06069102" }, { "nct_id": "NCT02587351", "title": "Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Metoprolol succinate", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "40 Years to 84 Years" }, "enrollment_count": 532, "start_date": "2016-05-01", "completion_date": "2019-12-01", "has_results": true, "last_update_posted_date": "2021-01-25", "last_synced_at": "2026-10-25T11:13:39.174Z", "location_count": 27, "location_summary": "Birmingham, Alabama • Fresno, California • Los Angeles, California + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Fresno", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02587351" } ] }